E-Cigarettes May Help Smokers With Schizophrenia Cut Tobacco Smoking
FRIDAY, March 19, 2021 -- High-strength nicotine electronic cigarettes have the potential to help people with schizophrenia spectrum disorders quit or reduce smoking, according to a study published online March 16 in Nicotine & Tobacco Research.
Pasquale Caponnetto, Ph.D., from the University of Catania in Italy, and colleagues assessed the feasibility of using a new-generation high-strength nicotine e-cigarette to modify smoking behavior in individuals with schizophrenia spectrum disorders who smoke cigarettes. Forty participants, with no intent to quit, were given a 12-week supply of a JUUL e-cigarette loaded with a 5 percent nicotine pod. Smoking cessation was evaluated at week 12.
Sixteen participants (40 percent) had quit smoking by the end of 12 weeks. Overall, the researchers observed a sustained 50 percent reduction in smoking or smoking abstinence in 37 of 40 participants (92.5 percent) and an overall 75 percent reduction in the median number of cigarettes smoked per day (from 25 to six).
"Considering that most people with schizophrenia spectrum disorders continue smoking, alternative and efficient interventions to reduce or prevent morbidity and mortality are urgently needed," the authors write.
PAX Labs provided free supplies of JUUL e-cigarette kits and pods.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
THURSDAY, April 8, 2021 -- Implementing the Quit Connect protocol in rheumatology clinics is feasible and increases electronic referrals to a state-run tobacco quit line,...
WEDNESDAY, April 7, 2021 -- A majority of electronic cigarette users express interest in eventually quitting vaping, according to a research letter published online April 2 in...
WEDNESDAY, March 31, 2021 -- Existing smokers or users of electronic nicotine delivery systems (ENDS) report increased use during the initial COVID-19 lockdown, according to a...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.